Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Opalka

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Leukemia Research|June 1, 1993
Analysis of the p53 gene in patients with isochromosome 17q and Ph1-positive or -negative myeloid leukemiaJ Schütte, B Opalka, R Becher, et al.
Blut|July 1, 1990
Treatment of chronic myelogenous leukemia with interferons alpha and gammaO Kloke, D May, U Wandl, et al.
Seminars in Oncology|April 1, 1992
Treatment of chronic myelogenous leukemia with different cytokinesU B Wandl, B Opalka, O Kloke, et al.
Leukemia Research|January 1, 1990
DNA-flow cytometry studies in blood and marrow cells from chronic myelogenous leukemia patients treated with interferon alpha-2bU B Wandl, D May, T Peltzer, et al.
Blood|February 15, 1989
A PvuII polymorphism of the bcr region in patients with hematopoietic disorders and their familiesB Opalka, U Wandl, O Kloke, et al.
Leukemia Research|February 1, 1996
Analysis of the novel cyclin-dependent kinase 4 and 6 inhibitor gene p18 in lymphoma and leukemia cell linesR Siebert, C P Willers, A Fosså, et al.
Leukemia|May 1, 1994
Bcr-abl-positive and -negative clonogenic cells in CML patients undergoing long-term interferon treatmentU B Wandl, R Bützler, N Niederle, et al.
Genomics|May 20, 1995
Precise localization of aphidicolin-induced breakpoints on the short arm of human chromosome 3W Paradee, C Mullins, Z He, et al.
British Journal of Haematology|May 1, 1996
BCR rearrangement without juxtaposition of ABL in pre-T acute lymphoblastic leukaemiaA Fosså, R Siebert, C Kasper, et al.
Lancet (London, England)|June 10, 1989
Elimination by interferon-alpha of malignant clone in chronic myeloid leukaemiaB Opalka, O Kloke, C R Bartram, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Leukemia Research|June 1, 1993
Analysis of the p53 gene in patients with isochromosome 17q and Ph1-positive or -negative myeloid leukemiaJ Schütte, B Opalka, R Becher, et al.
Blut|July 1, 1990
Treatment of chronic myelogenous leukemia with interferons alpha and gammaO Kloke, D May, U Wandl, et al.
Seminars in Oncology|April 1, 1992
Treatment of chronic myelogenous leukemia with different cytokinesU B Wandl, B Opalka, O Kloke, et al.
Leukemia Research|January 1, 1990
DNA-flow cytometry studies in blood and marrow cells from chronic myelogenous leukemia patients treated with interferon alpha-2bU B Wandl, D May, T Peltzer, et al.
Blood|February 15, 1989
A PvuII polymorphism of the bcr region in patients with hematopoietic disorders and their familiesB Opalka, U Wandl, O Kloke, et al.
Leukemia Research|February 1, 1996
Analysis of the novel cyclin-dependent kinase 4 and 6 inhibitor gene p18 in lymphoma and leukemia cell linesR Siebert, C P Willers, A Fosså, et al.
Leukemia|May 1, 1994
Bcr-abl-positive and -negative clonogenic cells in CML patients undergoing long-term interferon treatmentU B Wandl, R Bützler, N Niederle, et al.
Genomics|May 20, 1995
Precise localization of aphidicolin-induced breakpoints on the short arm of human chromosome 3W Paradee, C Mullins, Z He, et al.
British Journal of Haematology|May 1, 1996
BCR rearrangement without juxtaposition of ABL in pre-T acute lymphoblastic leukaemiaA Fosså, R Siebert, C Kasper, et al.
Lancet (London, England)|June 10, 1989
Elimination by interferon-alpha of malignant clone in chronic myeloid leukaemiaB Opalka, O Kloke, C R Bartram, et al.
Pageof 7